Lundbeck
HLUN-B.CO
#2596
Rank
โ‚น595.22 B
Marketcap
โ‚น627.16
Share price
0.63%
Change (1 day)
21.41%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Revenue for Lundbeck (HLUN-B.CO)

Revenue in 2025 (TTM): โ‚น312.88 Billion

According to Lundbeck's latest financial reports the company's current revenue (TTM ) is โ‚น324.86 Billion. In 2024 the company made a revenue of โ‚น272.64 Billion an increase over the revenue in the year 2023 that were of โ‚น240.89 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lundbeck from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น312.88 B14.76%
2024 โ‚น272.64 B13.18%
2023 โ‚น240.89 B12.98%
2022 โ‚น213.21 B12.47%
2021 โ‚น189.57 B-5.45%
2020 โ‚น200.49 B8.23%
2019 โ‚น185.24 B-6.1%
2018 โ‚น197.28 B16.16%
2017 โ‚น169.84 B7.67%
2016 โ‚น157.73 B10.39%
2015 โ‚น142.89 B-4.71%
2014 โ‚น149.95 B-10.53%
2013 โ‚น167.59 B18.28%
2012 โ‚น141.69 B-9.42%
2011 โ‚น156.43 B32.92%
2010 โ‚น117.69 B-2.35%
2009 โ‚น120.53 B